167 related articles for article (PubMed ID: 30569146)
1. A risk assessment model for the prognosis of osteosarcoma utilizing differentially expressed lncRNAs.
Sun K; Zhao J
Mol Med Rep; 2019 Feb; 19(2):1128-1138. PubMed ID: 30569146
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment model constructed by differentially expressed lncRNAs for the prognosis of glioma.
Hu C; Zhou Y; Liu C; Kang Y
Oncol Rep; 2018 Nov; 40(5):2467-2476. PubMed ID: 30106138
[TBL] [Abstract][Full Text] [Related]
3. The lncRNAs RP1-261G23.7, RP11-69E11.4 and SATB2-AS1 are a novel clinical signature for predicting recurrent osteosarcoma.
Ying T; Dong JL; Yuan C; Li P; Guo Q
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850493
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
5. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma.
Zhang K; Lu S; Jiang M; Zou X; Chen C; Lan Y; Zhao H; Ma R; Yan H
Front Biosci (Landmark Ed); 2024 May; 29(5):193. PubMed ID: 38812298
[TBL] [Abstract][Full Text] [Related]
6. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
7. The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Tumour Immune Analysis in Osteosarcoma.
Jiang J; Chu D; Lai X; Liu L; Tao J
Comput Math Methods Med; 2022; 2022():6314182. PubMed ID: 36388161
[TBL] [Abstract][Full Text] [Related]
8. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of a ceRNA Network Identifies lncR-C3orf35 Associated with Poor Prognosis in Osteosarcoma.
Shi Y; Ren J; Zhuang Z; Zhang W; Wang Z; Liu Y; Li J; Liang T; He R; Wang K
Biomed Res Int; 2020; 2020():3178037. PubMed ID: 33015161
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
[TBL] [Abstract][Full Text] [Related]
12. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
13. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
Zhu KP; Zhang CL; Shen GQ; Zhu ZS
Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of long noncoding RNA AC083900.1 and RP11-283C24.1 for prediction of progression of osteosarcoma.
Huang L; Jin W; Bao Y; Zeng X; Zhang Y; Zhou J; Peng H
Mutat Res; 2023; 827():111828. PubMed ID: 37437507
[TBL] [Abstract][Full Text] [Related]
18. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
[TBL] [Abstract][Full Text] [Related]
19. Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma.
Qiu L; Tao A; Liu F; Ge X; Li C
BMC Genom Data; 2022 Nov; 23(1):80. PubMed ID: 36384476
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]